{"product_id":"adventhealth-advanced-heart-failure-2025","title":"AdventHealth Advanced Heart Failure CME 2025","description":"\u003cdiv\u003e\n\u003cdiv class=\"prod-edition\"\u003e\n\u003ch3 class=\"product_title entry-title\"\u003eAdventHealth Advanced Heart Failure CME 2025\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 9 videos + 9 audio + 9 file sub vtt + 10 pdfs, size: 5.2 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: cardiologists, internists, advanced practice providers, and multidisciplinary heart failure teams\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThe purpose of this educational program is to educate regional providers on when to refer patients with heart failure for consideration for heart transplant and mechanical left ventricular support, to review other treatment options for complex heart conditions like aortic valve disease and infiltrative cardiomyopathies and ultimately lead to earlier referrals which will improve outcomes.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\n\u003cbr\u003e\u003cul class=\"carina-rte-public-DraftStyleDefault-ul\"\u003e\n\u003cli\u003eIdentify appropriate timing and indications for referral for heart transplantation and durable mechanical circulatory support.\u003c\/li\u003e\n\u003cli\u003eEvaluate treatment strategies for cardiogenic shock, including the application of echocardiography and hemodynamic monitoring.\u003c\/li\u003e\n\u003cli\u003eExplain the role of cardiogenomics in the management of patients with dilated cardiomyopathy.\u003c\/li\u003e\n\u003cli\u003eAnalyze the management of cardiogenic shock and acute myocardial infarction, with a focus on novel percutaneous devices and outcomes in elderly LVAD patients.\u003c\/li\u003e\n\u003cli\u003eDiscuss updated treatment options for patients with amyloidosis and hypertrophic cardiomyopathy.\u003c\/li\u003e\n\u003cli\u003eDescribe current approaches to expanding access to heart transplantation, including the use of ECMO, donation after circulatory death (DCD), and hepatitis C–positive donors.\u003c\/li\u003e\n\u003cli\u003eDiscuss the role of percutaneous valve interventions in patients with underlying heart failure.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eThe \u003cem\u003eAdventHealth Advanced Heart Failure CME 2025\u003c\/em\u003e program is best for cardiologists, internists, advanced practice providers, and multidisciplinary heart failure teams who want evidence‑based updates on the diagnosis and management of advanced heart failure. It emphasizes modern therapeutics, device‑based interventions, and collaborative care strategies to improve patient outcomes.\u003cbr\u003e\u003ch3\u003eWho Should Attend\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eCardiologists (general \u0026amp; advanced HF specialists) managing patients with complex heart failure.\u003c\/li\u003e\n\u003cli\u003eInternists \u0026amp; hospitalists encountering advanced HF in inpatient and outpatient settings.\u003c\/li\u003e\n\u003cli\u003eAdvanced practice providers (NPs, PAs) working in cardiology or internal medicine.\u003c\/li\u003e\n\u003cli\u003eCardiac surgeons \u0026amp; electrophysiologists integrating surgical and device‑based therapies.\u003c\/li\u003e\n\u003cli\u003eResidents \u0026amp; fellows in cardiology or internal medicine seeking advanced exposure.\u003c\/li\u003e\n\u003cli\u003eMultidisciplinary HF teams (nurses, pharmacists, rehab specialists) supporting patient care.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhat You’ll Learn\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAdvanced therapeutics: updates on guideline‑directed medical therapy (GDMT) and novel pharmacologic agents.\u003c\/li\u003e\n\u003cli\u003eDevice‑based interventions: LVADs, ICDs, CRT, and emerging mechanical circulatory support.\u003c\/li\u003e\n\u003cli\u003eTransplantation updates: patient selection, timing, and outcomes in heart transplantation.\u003c\/li\u003e\n\u003cli\u003eMultidisciplinary management: team‑based strategies for inpatient and outpatient HF care.\u003c\/li\u003e\n\u003cli\u003eCase‑based learning: real examples of advanced HF diagnosis and treatment.\u003c\/li\u003e\n\u003cli\u003eFuture directions: innovations in digital health, remote monitoring, and precision medicine.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e01 When to Refer the Patient with Advanced Heart Failure for Consideration For HF \u0026amp; LVAD\u003c\/li\u003e\n\u003cli\u003e02 Use of Cardiogenomics in Patients with Dilated Cardiomyopathy\u003c\/li\u003e\n\u003cli\u003e03 Use of Echocardiography and Hemodynamics and Patients with Cardiogenic Shock\u003c\/li\u003e\n\u003cli\u003e04 Cardiogenic Shock and Acute Myocardial Infarction\u003c\/li\u003e\n\u003cli\u003e05 Outcomes in Elderly LVAD Patients\u003c\/li\u003e\n\u003cli\u003e06 Frailty Assessment in the Evaluation for Advanced Heart Failure Surgical Therapies (LVAD and Transplant)\u003c\/li\u003e\n\u003cli\u003e07 Updated Treatment Options for Patients with Amyloid \u0026amp; Hypertrophic Cardiomyopathy\u003c\/li\u003e\n\u003cli\u003e08 Novel Percutaneous Devices in the Management of Cardiogenic Shock\u003c\/li\u003e\n\u003cli\u003e09 Strategies to Increase Access to Heart Transplantation- Use of ECMO, Donation After Cardiac Death, and Hepatitis C Positive Donors\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"related products\"\u003e\u003c\/section\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954548314210,"sku":"MED-AMB05883","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/file_000000006b3c71f69561c26626f28461.png?v=1779379504","url":"https:\/\/meducourse.com\/products\/adventhealth-advanced-heart-failure-2025","provider":"Meducourse","version":"1.0","type":"link"}